Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /

The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...

Full description

Saved in:
Bibliographic Details
Main Author: Reepmeyer, Gerrit. (Author, http://id.loc.gov/vocabulary/relators/aut)
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Language:English
Published: Heidelberg : Physica-Verlag HD : Imprint: Physica, 2006.
Edition:1st ed. 2006.
Series:Contributions to Management Science,
Subjects:
Online Access:https://doi.org/10.1007/3-7908-1668-X
Tags: Add Tag
No Tags, Be the first to tag this record!